Veronica Costa

Title: Innovations by Veronica Costa

Introduction

Veronica Costa is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the study of UBE3A protein targets and their implications for treating genetic disorders.

Latest Patents

Veronica holds a total of seven patents. Her latest inventions include the development of E3 ubiquitin ligase (UBE3A) protein targets, which serve as target engagement biomarkers for compounds that modulate UBE3A expression. Another notable patent involves oligonucleotides designed to induce paternal UBE3A expression. This invention focuses on oligonucleotides that can activate the expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele in neurons. These oligonucleotides target the suppressor of the UBE3A paternal allele by hybridizing to SNHG14 long non-coding RNA downstream of SNORD1091B. Additionally, this invention relates to pharmaceutical compositions and methods for treating Angelman syndrome.

Career Highlights

Throughout her career, Veronica has worked with notable companies such as Hoffmann-La Roche Inc. and Roche Innovation Center Copenhagen A/S. Her work has significantly advanced the understanding of UBE3A and its potential therapeutic applications.

Collaborations

Veronica has collaborated with esteemed colleagues, including Maj Hedtjärn and Marius Hoener, to further her research and innovations in the field.

Conclusion

Veronica Costa's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in genetic research and treatment options.